NeuPath Health

NeuPath Health Market capitalization

The The market capitalization of NeuPath Health (NPTH.V) as of Nov 12, 2026 is 23.39 M CAD. In the previous year, The market capitalization was 23.39 M CAD — a change of 0.00% (lower).

Market capitalization

23.39 MCAD

YoY

0.00%

Last updated:

In 2025, NeuPath Health's market cap stood at 23.39 M CAD, a 0.00% increase from the 23.39 M CAD market cap in the previous year.

The NeuPath Health Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
23.39 M CAD
Jan 1, 2019
23.39 M CAD
Jan 1, 2020
23.39 M CAD
Jan 1, 2021
23.39 M CAD
Jan 1, 2022
23.39 M CAD
Jan 1, 2023
23.39 M CAD
Jan 1, 2024
23.39 M CAD
Jan 1, 2025
23.39 M CAD
The NeuPath Health Market capitalization history
YEARMarket capitalizationYoY
23.39 MCAD0.00%
23.39 MCAD0.00%
23.39 MCAD0.00%
23.39 MCAD0.00%
23.39 MCAD0.00%
23.39 MCAD0.00%
23.39 MCAD0.00%
23.39 MCAD0.00%
23.39 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health Stock analysis

What does NeuPath Health do? NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients. NeuPath Health is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring NeuPath Health's Market Capitalization

NeuPath Health's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of NeuPath Health's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

NeuPath Health's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in NeuPath Health’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about NeuPath Health stock

The market capitalization of NeuPath Health is 23.39 M CAD in 2025.

The market capitalization of NeuPath Health changed from 23.39 M CAD to 23.39 M CAD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization NeuPath Health since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's CAD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' CAD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's NeuPath Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — NeuPath Health

All Key Metrics — NeuPath Health